The rising burden of surgical diseases and the growing number of surgical procedures drive the demand for airway management devices. As surgical volumes increase, so does the need for tools that facilitate secure airway control and ventilation during anesthesia administration. The prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, has been on the rise. Patients with these conditions may require airway management devices for both acute exacerbations and chronic management, contributing to market growth.
Ongoing technological advancements in airway management devices enhance their effectiveness, safety, and ease of use. Developing novel materials, innovative designs, and integrated monitoring features contributes to the market's expansion as healthcare providers seek state-of-the-art solutions. Patient safety remains a top priority in healthcare, prompting the adoption of airway management devices that reduce the risk of complications and improve overall outcomes. Manufacturers invest in research and development to design devices prioritizing patient safety and comfort. The aging population is associated with an increased prevalence of conditions that may require airway management, such as surgeries and respiratory illnesses. The geriatric demographic's unique healthcare needs drive the demand for specialized airway management devices catering to this population.
Increasing economic prosperity in many countries within the Asia Pacific region has led to higher healthcare expenditure. As governments invest more in healthcare infrastructure, there is a corresponding growth in the demand for advanced medical technologies, including airway management devices. Therefore, due to the above-mentioned factors, the airway management devices market will grow significantly in this region.
The China market dominated the Asia Pacific Airway Management Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $257.2 million by 2030. The Japan market is registering a CAGR of 7.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 8.6% during (2023 - 2030).
Based on Application, the market is segmented into Anesthesia, Emergency Medicine, and Others. Based on End-use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Supraglottic Devices (Oropharyngeal Devices, Nasopharyngeal Devices, Laryngeal Airway Masks, and Others), Infraglottic Devices (Endotracheal Tubes, Tracheostomy Tubes, and Others), Laryngoscopes, Resuscitators, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Medtronic PLC
- Teleflex Incorporated
- Ambu A/S
- Becton, Dickinson, and Company
- Medline Industries, Inc.
- ICU Medical, Inc. (Smiths Medical)
- ConvaTec Group PLC
- Armstrong Medical Ltd
- Intersurgical Ltd
- Mercury Medical
Market Report Segmentation
By Application- Anesthesia
- Emergency Medicine
- Others
- Hospitals
- Homecare
- Others
- Supraglottic Devices
- Oropharyngeal Devices
- Nasopharyngeal Devices
- Laryngeal Airway Masks
- Others
- Infraglottic Devices
- Endotracheal Tubes
- Tracheos tomy Tubes
- Others
- Laryngoscopes
- Resuscitators
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Medtronic PLC
- Teleflex Incorporated
- Ambu A/S
- Becton, Dickinson, and Company
- Medline Industries, Inc.
- ICU Medical, Inc. (Smiths Medical)
- ConvaTec Group PLC
- Armstrong Medical Ltd
- Intersurgical Ltd
- Mercury Medical
Methodology
LOADING...